Labcorp Expands MRD Testing to Enhance Detection of Cancer Recurrence for Breast, Lung, and Colon Cancers Labcorp's recent expansion of molecular residual disease testing aims to provide early detection of cancer recurrence, improving patient care in breast, lung, and colon cancers.

Labcorp Expands MRD Testing to Enhance Detection of Cancer Recurrence for Breast, Lung, and Colon Cancers #United_States #Burlington #Labcorp #MRD_Testing #Cancer_Recurrence